Moteur de recherche d’entreprises européennes
Financement de l’UE (150 000 €) : Patch de micro-aiguilles photothermiques plasmoniques hybrides chargé de médicaments contre les infections cutanées Hor01/04/2021 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Patch de micro-aiguilles photothermiques plasmoniques hybrides chargé de médicaments contre les infections cutanées
In this proof of concept project, we will assess the technical and commercial feasibility of a hybrid microneedle patch for the treatment of nosocomial skin infections caused by drug resistant bacteria. Not only does this device permeate difficult-to-penetrate skin layers to deliver antibiotics locally, it also weakens bacterial defences by raising local temperature to enhance drug effectiveness. In this manner, the need for high dosage systemic drug administration is avoided – reducing occurrence of associated side-effects and perpetuation of antimicrobial resistance. It holds the potential not only to revitalise antibacterials for topical, local treatment of skin infections, but to improve dermatological drug delivery as a platform device. In this project, we will validate the device’s fabrication process for additional commercial scalability and functionality with nanocarrier-drug complexes (for enhanced effectiveness of drug delivery to target site), develop a robust IP strategy and secure initial patents, and conduct extensive market analyses and competitor landscaping. Finally, we will formulate a strong business case, and depending on the results of these activities, establish a company.
| Karolinska Institutet | 100 000 € |
| Karolinska Institutet Holding AB | 50 000 € |
https://cordis.europa.eu/project/id/966636
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
